Clofazimine. A new agent for the treatment of pyoderma gangrenosum
- 1 March 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (3) , 344-349
- https://doi.org/10.1001/archderm.112.3.344
Abstract
Patients (8) had pyoderma gangrenosum. They were given a phendimetrazine tartrate derivative, clofazimine, which is a chemotherapeutic agent used mainly in certain mycobacterial infections and which also has phagocytosis-enhancing properties. The effect of this drug was remarkably good, with rapid healing of the lesions commencing 3-14 days after treatment was started. The mechanism for the effect of clofazimine in pyoderma gangrenosum is not known.This publication has 0 references indexed in Scilit: